Merck & Co., Inc. NYSE: MRK has filed 13-F forms with the SEC as an investor. Merck & Co., Inc. is itself a publicly traded company. Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. For more information on Merck & Co., Inc. stock, visit the Merck & Co., Inc. stock profile here.
Investment Activity
- Merck & Co., Inc. has $164.28 million in total holdings as of December 31, 2024.
- Merck & Co., Inc. owns shares of 12 different stocks, but just 3 companies or ETFs make up 80% of its holdings.
- Approximately 0.76% of the portfolio was purchased this quarter.
- About 1.59% of the portfolio was sold this quarter.
- This quarter, Merck & Co., Inc. has purchased 13 new stocks and bought additional shares in 1 stock.
- Merck & Co., Inc. sold shares of 0 stocks and completely divested from 1 stock this quarter.
Largest Holdings
- ENTRADA THERAPEUTICS INC
- $15,727,503
Largest Purchases this Quarter
- EVAXION BIOTECH A/S
- 671,847 shares (about $1.24M)
